Baxter International (NYSE:BAX) PT Raised to $44.00

Baxter International (NYSE:BAX – Free Report) had its target price raised by Citigroup from $41.00 to $44.00 in a report published on Wednesday morning, Benzinga reports. Citigroup currently has a neutral rating on the medical instruments supplier’s stock. Several other brokerages have also recently issued reports on BAX. Barclays raised their target price on Baxter […]

Related Keywords

United States ,America , ,Barclays ,Baxter International Inc ,Shapiro Capital Management ,Baxter International ,Baxter International Dividend Announcement ,Institutional Trading Of Baxter International ,York Mellon Corp ,Baxter International Trading ,Analyst Recommendations For Baxter International ,Baxter International Company Profile ,Jpmorgan Chase Co ,News Ratings For Baxter International Daily ,Pzena Investment Management ,Citigroup ,Free Report ,Get Free Report ,Investment Management ,Capital Management ,New York Mellon Corp ,International Inc ,Medical Products ,Healthcare Systems ,Baxter International Daily ,Nyse Bax ,Bax ,Medical ,07181310 ,Boost Price Target ,Citigroup Inc ,